compound
AICAR (50 mg Vial) Questions Answered
AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a research compound that activates AMP-activated protein kinase (AMPK) [1] , earning the nickname “exercise pill” after studies showed sedentary animals given AICAR experienced dramatic endurance impr...
AICAR (50 mg Vial)
Week/Phase Daily Dose Units (per injection) (mL) Weeks 1–2 1,000 mcg (1 mg) 6 units (0.06 mL) Weeks 3–4 2,000 mcg (2 mg) 12 units (0.12 mL) Weeks 5–8 3,000 mcg (3 mg) 18 units (0.18 mL) Frequency: Inject once daily subcutaneously [3] .
AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a research compound that activates AMP-activated protein kinase (AMPK) [1] , earning the nickname “exercise pill” after studies showed sedentary animals given AICAR experienced dramatic endurance impr...
Week/Phase Daily Dose Units (per injection) (mL) Weeks 1–2 1,000 mcg (1 mg) 6 units (0.06 mL) Weeks 3–4 2,000 mcg (2 mg) 12 units (0.12 mL) Weeks 5–8 3,000 mcg (3 mg) 18 units (0.18 mL) Frequency: Inject once daily subcutaneously [3] .
Plan based on an 8-week research protocol (conservative dosing). Peptide Vials (AICAR, 50 mg each): 8 weeks (gradual 1–3 mg/day) ≈ 3 vials 12 weeks (2–5 mg/day advanced) ≈ 8 vials Insulin Syringes (U-100, or 30/50-unit for precision): Per week: 7 syringes (...